Table 3.
Type of analysis | Stage 1 | Stage 2 | Stage 1 and 2 (combined) | ||||
---|---|---|---|---|---|---|---|
SNP tested | Adjustments | OR (95% CI) | p Value | OR (95% CI) | p Value | OR (95% CI) | p Value |
rs13361160 | Age, BMI, and 4 PCs | 1.30 (1.19 to 1.42) | 1.18×10−8 | 1.06 (0.98 to 1.16) | 0.16 | 1.17 (1.10 to 1.24) | 4.67×10−7 |
(minor allele=C, other allele=T, MAF=43.5%) | |||||||
Sensitivity analysis; joint pain only | |||||||
rs13361160 | Age, BMI, and 4 PCs | 1.30 (1.19 to 1.42) | 1.18×10−8 | 1.10 (0.97 to 1.25) | 0.15 | 1.23 (1.14 to 1.32) | 3.43×10−8 |
(minor allele=C, other allele=T, MAF=43.5%) |
In both analyses the effect estimates of the models refer to the minor allele (=effect allele).
BMI, body mass index; MAF, minor allele frequency.